arrow
C

Charu Aggarwal

University of Pennsylvania
H指数:47
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes Following First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy Stratified by KRAS Mutational Status—A Real-World Analysis in Patients With Advanced NSCLC

KRAS突变状态分层下,一线免疫检查点抑制剂联合或不联合化疗的疗效分析——一项在晚期非小细胞肺癌患者中的真实世界研究

2025-05-280
PRE
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis

改变EGFR突变的NSCLC患者的治疗和转移性疾病模式: 学术胸科医学研究者的联盟注册分析

2025-01-010
OA
Precision Oncology: A Global Perspective on Implementation and Policy Development
2025-01-010
OA
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC

EGFR突变转移性NSCLC长期存活者的特征

2024-08-012
OA
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab Consolidation
2024-05-014
PRE
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
2024-05-014
PRE
Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
2024-05-011
PRE
Results from KEYMAKER-U01 substudy 3: a phase 2 umbrella study of pembrolizumab plus investigational agents in patients with non-small-cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy
2024-04-050
PRE